Related Experiment Videos
MODS/SIRS: result of an overwhelming inflammatory response?
1Department of Surgery, University Hospital Nijmegen, 6500 HB Nijmegen, The Netherlands.
World Journal of Surgery
|May 1, 1996
Summary
Multiple organ dysfunction syndrome (MODS) and systemic inflammatory response syndrome (SIRS) stem from inappropriate inflammation. Modulating phagocyte activation, rather than just treating causes, may improve outcomes for these critical conditions.
Area of Science:
- Critical care medicine
- Immunology
- Pathophysiology
Background:
- Multiple organ dysfunction syndrome (MODS) and systemic inflammatory response syndrome (SIRS) are severe, generalized inflammatory conditions.
- These syndromes result from inappropriate inflammatory responses to various stimuli, including bacterial and nonbacterial causes.
- Phagocyte activation appears central to the clinical manifestations and pathophysiology of MODS and SIRS.
Purpose of the Study:
- To highlight the central role of phagocyte activation in MODS and SIRS.
- To discuss the limitations of current treatments targeting the underlying causes.
- To propose modulating phagocyte response as a potential therapeutic strategy.
Main Methods:
- Review of existing literature on MODS and SIRS pathophysiology.
- Analysis of the role of phagocyte activation in observed clinical and morphologic changes.
- Evaluation of the efficacy of current treatment paradigms.
Main Results:
- Clinical signs, symptoms, and organ damage in MODS/SIRS are linked to phagocyte activation.
- Treatments focused on identifying microorganisms and neutralizing toxins have not significantly improved patient prognosis.
- The generalized inflammatory response is a key feature, regardless of the initial stimulus (bacterial or nonbacterial).
Conclusions:
- Phagocyte activation is a critical mediator in the development of MODS and SIRS.
- Current strategies targeting the initial cause are insufficient for improving outcomes.
- Developing safe methods to modulate the phagocyte response is a promising adjunctive therapeutic approach.